TOZYRE
DEAD

Serial Number

87780177

Owner

SK Biopharmaceuticals Co., Ltd.

Attorney

Hun Joon Kim

Filing Date

Feb 1, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TOZYRE Trademark

Serial Number: 87780177 • Registration: 5719313

TOZYRE is a trademark filed by SK Biopharmaceuticals Co., Ltd. on February 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

SK Biopharmaceuticals Co., Ltd. (18 trademarks)

221, Pangyoyeok-ro
Gyeonggi-do 13494 , KR

Entity Type: 03

Trademark Details

Filing Date

February 1, 2018

Registration Date

April 9, 2019

Published for Opposition

January 22, 2019

Cancellation Date

October 24, 2025

Goods & Services

Pharmaceutical and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; blood solvent; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 24, 2025 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 27, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 27, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 27, 2024 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 9, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 4, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 4, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 4, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 4, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 4, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 4, 2020 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2019 TCCA
REGISTERED-PRINCIPAL REGISTER
Apr 9, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 2, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2018 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 12, 2018 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2018 CRFA
ASSIGNED TO LIE
Dec 4, 2018 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 28, 2018 TCCA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 28, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 14, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 14, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 14, 2018 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 16, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
May 16, 2018 GNSL
SUSPENSION LETTER WRITTEN
May 16, 2018 CNSL
ASSIGNED TO EXAMINER
May 15, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2018 NWOS
NEW APPLICATION ENTERED
Feb 5, 2018 NWAP